The effect of amlodipine on blood glucose level and its interaction with oral hypoglycemic drugs in albino rabbits
Keywords:
Amlodipine, Diabetes, Hypoglycemia, HyperglycemiaAbstract
Background: Amlodipine used as many cardiac conditions esp in hypertension. Diabetes affects cardiovascular system adversely. So this study was done to see effect of amlodipine on blood glucose level and its interaction with commonly used oral hypoglycemic agents in diabetic & non diabetic albino rabbits.
Methods: Rabbits were divided into nine groups of 6 rabbits in each group. I and II group were non-diabetic given normal saline and amlodipine respectively. Group III to IX were made diabetic by using alloxan monohydrate (150mg/kg i.p.) & given normal saline, glimepiride, metformin, pioglitazone, amlodipine + glimepiride, amlodipine + metformin and amlodipine + pioglitazone respectively. All drugs were given orally once daily for 7 day except group VII, VIII and IX in which glimepiride, metformin and pioglitazone were added on 7th day. After GTT blood glucose level were measured at 0, 1, 2 and 6 hours on 7th day in all groups by using spectrophotometer.
Results: After 7 days of treatment the amlodipine produced significant hyperglycemia in normal rabbits. Amlodipine on combination, causes significant decreased in hypoglycemic effect of glimepiride, significant increased the hypoglycemic effect of metformin, while no significant changes in hypoglycemic effects of pioglitazone in diabetic rabbits.
Conclusion: The present study shows that amlodipine causes hyperglycemia in normal rabbits. Amlodipine significantly altered hypoglycemic effect of glimepiride and metformin as compared to control group. If these finding are true to human beings then amlodipine should be use cautiously in diabetic patient on oral hypoglycemic drugs.
References
Manjunath s, Santosh N, Kugali, Pridarshani M, Deodurg. Effect of clonidine on blood glucose level in euglycemic and alloxon induced diabetic rats and its interaction with glibenclamide. Ind J Pharmacol 2009;41:218-20.
Bruton LL, Laso JS, Parker KL. Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia, Goodman Gilman’s, The Pharmacological basis of Therapeutics, 12th ed: Mcgraw-hill medical publishing division, 2011: 755-60.
Kasper DL, Braunwald E, Fauci AN, Haucer SL, Longo DL, Jameson JL. Diabetes mellitus. Principal of internal medicine, 17th ed: McGraw Hill, 2010; 2275-7.
Das HN, Roy RK, Mandal S, Das AK, Kumar S, Maitra SK, et al. Comparative studies of the effects of calcium channel blockers on glucose tolerance in normal rats. Ind J Pharmacol 1993;25:170-2.
Bruton LL, Laso JS and Parker KL. Calcium channels antagonist, Goodman and Gilman, The Pharmacological basis of Therapeutics, 11th ed: Mcgraw-hill companies, 2005:1632.
Leuters LL, Stehouwer N, Rekman J, Tidball A, Cok A, Holstege CP. Amlodipine inhibit the glucose transport activity of GLUT-1. Eur J Clin Pharmacol 1993;45:345-9.
Segreta JM, Caulin C, Dahan R, Houlbert D, Thiercelin JF, Herman P, et al. Effect of diltiazem on plasma glucose, insulin and Glucagon during an oral glucose tolerance test in healthy volunteers. Eur J Clin Pharmacol 1984;26:481-5.
Ghosh MN. Toxicity studies, Fundamental of experimental pharmacology, 3rd ed. S.K. Ghosh & others, 2005:192-3.
Whittington KB, Solomen S, Lu N. Oral glucose tolerance test in diabetic experimental animals. Endocrinology. 1991;128:2671-7.
Levine M, Boyer EW, Pozner CN, Gebi AJ, Thomsen T, Mick N, Thomas SH. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or amlodipine. Crit Care Med. 2007 Sep;35(9):2071-5.
Rave K, Flesch S, Kuhn VW. Effect on blood glucose level when sulphonylureas co-administered with CCBs: Results of a glucose-clamp study. Diabetes Metabolism Research and Reviews 2005;21:357-9.
Bruton LL, Laso JS, Parker KL. Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia, Goodman and Gilman’s, The Pharmacological basis of Therapeutics, 12th ed. McGraw-Hill companies, 2011:1255-7.
Torlano E, Allen Di TJ, Cao Z. Improved glycemic control and insulin action after long term use of amlodipine with metformin in subject with arterial hypertension and type-2 diabetes. Diabetic Care 1993 Sep;13(7):1347-55.
Brichard S, Ktelsleger JM, Lambert AE. Renal function, glycemic control and pioglitazone in diabetics. Arch Mal Coeur Vaiss 1989;82:65-7.
